Courtney DiNardo

Assistant Professor

  • 6767 Bertner Ave, Mitchell Basic Science Research Building

    77030 Houston

    United States

  • 2396 Citations
  • 24 h-Index
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 29 Similar Profiles
Acute Myeloid Leukemia Medicine & Life Sciences
Myelodysplastic Syndromes Medicine & Life Sciences
Isocitrate Dehydrogenase Medicine & Life Sciences
Mutation Medicine & Life Sciences
decitabine Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Azacitidine Medicine & Life Sciences
Neoplasms Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2007 2019

1 Citation (Scopus)

Advances in patient care through increasingly individualized therapy

DiNardo, C. & Perl, A. E., Feb 1 2019, In : Nature Reviews Clinical Oncology. 16, 2, p. 73-74 2 p.

Research output: Contribution to journalArticle

Patient Care
Acute Myeloid Leukemia
Gene Expression
Leukemia, Myelomonocytic, Chronic
Myelodysplastic Syndromes
4 Citations (Scopus)
Open Access
Acute Myeloid Leukemia
Bone Marrow

Enasidenib, an inhibitor of mutant IDH2 proteins, induces durable remissions in older patients with newly diagnosed acute myeloid leukemia

Pollyea, D. A., Tallman, M. S., de Botton, S., Kantarjian, H. M., Collins, R., Stein, A. S., Frattini, M. G., Xu, Q., Tosolini, A., See, W. L., MacBeth, K. J., Agresta, S. V., Attar, E. C., DiNardo, C. & Stein, E. M., Jan 1 2019, In : Leukemia.

Research output: Contribution to journalArticle

Open Access
Isocitrate Dehydrogenase
Acute Myeloid Leukemia
Hematologic Neoplasms
Germ-Line Mutation
Cytogenetic Analysis
Myelodysplastic Syndromes